Quarterly report · Q2
4272.TEDINET S100PHL2
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥102.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥184.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥88.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥13.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥10.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥16.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.2bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.8bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥16.4bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥9.3bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥329.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥315.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥302.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥70.3bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥69.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥259.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥246.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥233.5bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥41.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥38.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥52.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥50.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥47.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥9.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥6.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥11.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥67.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.7 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.27 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.35 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥67.02 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.65 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥54.26 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 78.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥4.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥55m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥899m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥137m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥137m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥3.7bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥46.1bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥46.0bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.8bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥26.7bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥26.7bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.0bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥98.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥98.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥16.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥102.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥102.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥137m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥51m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥919m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥123m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥123m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥3.4bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥37.7bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥37.6bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥71m |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥3.2bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥84.8bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥84.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥71m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥89.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥88.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥123m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥14.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 583
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | CurrentYTDDuration | 11324000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 46000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 43000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 9205000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 11281000000 | JPY |
| Profit loss | Prior1YTDDuration | 9251000000 | JPY |
| Profit loss | CurrentYTDDuration | 11324000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 120000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -1431000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 1308000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 7214000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -20000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -173000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | -3000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 0 | JPY |
| Other comprehensive income | Prior1YTDDuration | 1404000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 5610000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 10655000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 16935000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 10590000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 16807000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 65000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 127000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 12972000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 16445000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 6631000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 6655000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 265000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 272000000 | JPY |
| Increase decrease in provision ope cf | Prior1YTDDuration | -88000000 | JPY |
| Increase decrease in provision ope cf | CurrentYTDDuration | -114000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -607000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -741000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 39000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 41000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -324000000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -1570000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | -245000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -6000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1YTDDuration | -1372000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | CurrentYTDDuration | -31000000 | JPY |
| Loss gain on disposal of property plant and equipment ope cf | Prior1YTDDuration | 252000000 | JPY |
| Loss gain on disposal of property plant and equipment ope cf | CurrentYTDDuration | 211000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | -81000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | － | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | 57000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 3000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 4870000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 2011000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -8129000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |